A carregar...
Publicação
Pfizer company outlook: a "Covid-19 dependent" business?
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.02 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This equity report aims at analyzing and evaluating the pharmaceutical company Pfizer in a context of the global pandemic and the possible outcomes of the post-pandemic. We also researched the latest industry trends and analyzed the pharma regulation, M&A activity, patents, and emerging technologies. Thorough the report, we explained the methodologies and how recent industry and economic factors will affect the revenues of the main Pfizer’s pharmaceutical products
Descrição
Palavras-chave
Valuation Innovation R&D Healthcare Covid Vaccines Patents Oncology